Form 4: Bausch Health Director Brett Icahn Receives Equity Compensation
Insider Transaction Report
Bausch Health Companies Inc. Director Brett Icahn was granted 4,034 Restricted Share Units as compensation for his board service for the quarter ending June 30, 2025.
Summary
- Brett Icahn, a Director and 10% Owner of Bausch Health Companies Inc. (BHC), acquired 4,034 common shares.
- The acquisition occurred on June 30, 2025.
- These shares were issued as Restricted Share Units (RSUs) in lieu of cash compensation for his service on the Issuer's Board of Directors for the quarter ending June 30, 2025.
- Each RSU represents a contingent right to receive one common share, no par value, of the Issuer.
- The transaction price was $0 per share, indicating it was compensation.
- Following this transaction, Brett Icahn beneficially owns 220,280 common shares.
Sentiment
Score: 7
Explanation: The filing indicates a routine, positive event of director equity compensation, aligning interests. No negative or unexpected elements are present.
Positives
- Issuance of Restricted Share Units to a director aligns the director's interests with long-term shareholder value.
- The director's increased beneficial ownership demonstrates continued commitment to the company.
Future Outlook
The document does not provide forward-looking statements or guidance beyond the nature of the compensation.
Industry Context
This Form 4 filing reflects a standard practice of compensating board members with equity, which is common across various industries to align director incentives with shareholder interests. It does not provide broader industry trends.
Comparison to Industry Standards
- Compensating directors with equity, such as Restricted Share Units, is a widely accepted corporate governance practice across industries, including pharmaceuticals and healthcare, as it aligns director incentives with long-term shareholder value.
- The grant of 4,034 RSUs to a director of a company like Bausch Health, with a market capitalization in the billions, is a typical component of a director's compensation package, comparable to practices at peer companies in the healthcare sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Implementation | Issuance of Restricted Share Units in lieu of cash compensation for board service, reflecting the company's established director compensation policy. | 06/30/2025 | Aligns director incentives with long-term shareholder value and promotes equity ownership among board members. |
Related Party Transactions
- The transaction involves a director receiving compensation, which is a related party transaction, but it is a standard, disclosed compensation event rather than an unusual dealing.
Stakeholder Impact
- Shareholders: The issuance of equity compensation to a director aligns the director's financial interests with those of the shareholders, potentially fostering decisions that enhance long-term share value.
- Employees: No direct impact on employees is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of transaction; Restricted Share Units issued for board service for the quarter ending this date. |
| 07/02/2025 | Date the Form 4 was signed and filed. |
Recommendation
holdKeywords
Bausch Health Companies Inc., BHC, Brett Icahn, Form 4, SEC filing, Restricted Share Units, RSU, equity compensation, director compensation, insider transaction, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.